Patrick Sweigert, a bariatric surgeon at the Ohio State University Wexner Medical Center, said in a news release.Were entering a new world of multidisciplinary care pathways and a new frontier of weight management that is important for patients and surgeons to think about, Sweigert added.Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.More informationJohn Hopkins Bloomberg School of Public Health has more on GLP-1 drug use among weight-loss surgery patients.SOURCE: American College of Surgeons, news release, Oct
The ABCs of what Joe Rogan puts in his body | The Daily Show
But medications for opioid use disorder the gold standard for treatment, along with counseling and other measures remain underused
This data allows PlexusDx to identify whether oral semaglutide, tirzepatide, or a dual-compound approach would deliver faster results tailored to your biology
Iron causes lipid oxidation and inhibits proteasome function in multiple myeloma cells: a proof of concept for novel combination therapies
A 10 mg vial reconstituted with 2 mL produces 5 mg/mL